Phaseline

Targets › SCFA

SCFA: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 2; Oncology; next expected readout Dec 2026.

Open in Phaseline: the race on SCFA, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Center Eugene MarquisEXL01
Single strain Faecalibacterium prausnitzii to modulate gut microbiota and enhance immunoth
SCFAPhase 2Hepatocellular CarcinomaDec 2026

Conditions

Hepatocellular Carcinoma (1)

Modalities

small molecule (1)

Companies

Center Eugene Marquis (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.